학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 187건 | 목록 1~20
Schröder M; Novartis Institutes for BioMedical Research, Basel, Switzerland. martin-1.schroeder@novartis.com.; Renatus M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland.; Liang X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Meili F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Zoller T; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ferrand S; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Gauter F; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Li X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Sigoillot F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Gleim S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Stachyra TM; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Thomas JR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Begue D; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Khoshouei M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Lefeuvre P; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Andraos-Rey R; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Chung B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Ma R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Pinch B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Hofmann A; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Schirle M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Schmiedeberg N; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Imbach P; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Gorses D; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Calkins K; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Bauer-Probst B; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Maschlej M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Niederst M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Maher R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Henault M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Alford J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Ahrne E; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Tordella L; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Hollingworth G; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Thomä NH; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Vulpetti A; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Radimerski T; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland.; Holzer P; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Carbonneau S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Thoma CR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. cthoma@ridgelinediscovery.com.; Ridgeline Discovery, Basel, Switzerland. cthoma@ridgelinediscovery.com.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Schröder M; Novartis Institutes for BioMedical Research, Basel, Switzerland. martin-1.schroeder@novartis.com.; Renatus M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland.; Liang X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Meili F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Zoller T; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ferrand S; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Gauter F; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Li X; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Sigoillot F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Gleim S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Stachyra TM; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Thomas JR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Begue D; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Khoshouei M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Lefeuvre P; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Andraos-Rey R; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Chung B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Ma R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Pinch B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Hofmann A; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Schirle M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Schmiedeberg N; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Imbach P; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Gorses D; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Calkins K; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Bauer-Probst B; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Maschlej M; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Niederst M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Maher R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Henault M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Alford J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Ahrne E; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Tordella L; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Hollingworth G; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Thomä NH; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Swiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Vulpetti A; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Radimerski T; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ridgeline Discovery, Basel, Switzerland.; Holzer P; Novartis Institutes for BioMedical Research, Basel, Switzerland.; Carbonneau S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.; Thoma CR; Novartis Institutes for BioMedical Research, Cambridge, MA, USA. cthoma@ridgelinediscovery.com.; Ridgeline Discovery, Basel, Switzerland. cthoma@ridgelinediscovery.com.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Pissot Soldermann C; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Simic O; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Renatus M; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Erbel P; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Melkko S; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Wartmann M; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Bigaud M; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Weiss A; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; McSheehy P; Basilea Pharmaceutica, CH-4002 Basel, Switzerland.; Endres RSantos PBlank J; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Schuffenhauer A; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Bold G; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Buschmann N; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Zoller T; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Altmann E; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Manley PW; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Dix I; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Buchdunger E; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Scesa J; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Quancard J; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Schlapbach A; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Bornancin F; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.; Radimerski T; Basilea Pharmaceutica, CH-4002 Basel, Switzerland.; Régnier CH; Novartis Institutes for BioMedical Research, Novartis Campus, CH-4002 Basel, Switzerland.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Academic Journal
Zhang A; Global Discovery Chemistry, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States.; Seiss K; Oncology Biotherapeutics, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States.; Laborde L; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Palacio-Ramirez S; Novartis Biologics Center, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States.; Guthy D; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Lanter M; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Lorber J; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Vulpetti A; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Arista L; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Zoller T; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Radimerski T; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Thoma C; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Hebach C; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Tschantz WR; Novartis Biologics Center, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States.; Karpov A; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Hollingworth GJ; Global Discovery Chemistry, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; D'Alessio JA; Oncology Biotherapeutics, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States.; Ferretti S; Oncology, Novartis Biomedical Research, CH-4002 Basel, Switzerland.; Burger MT; Global Discovery Chemistry, Novartis Biomedical Research, Cambridge, Massachusetts 02139 United States.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 9010319 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4812 (Electronic) Linking ISSN: 10431802 NLM ISO Abbreviation: Bioconjug Chem Subsets: MEDLINE
Academic Journal
Chapeau EA; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Mandon E; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Gill J; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Romanet V; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ebel N; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Powajbo V; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Andraos-Rey R; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Qian Z; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Kininis M; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Zumstein-Mecker S; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ito M; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Hynes NE; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; Tiedt R; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Hofmann F; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Eshkind L; Institute for Translational Immunology and Research Center for Immunotherapy, University Medical Center, Johannes Gutenberg University, Mainz, Germany.; Bockamp E; Institute for Translational Immunology and Research Center for Immunotherapy, University Medical Center, Johannes Gutenberg University, Mainz, Germany.; Kinzel B; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Mueller M; Chemical Biology and Therapeutics, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Murakami M; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Baffert F; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Radimerski T; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Academic Journal
Tognon R; Departmento de Análises Clínicas Toxicológicas e Bromatológicas da Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Brazil.; Departamento de Farmácia, Instituto Ciências da Vida, Universidade Federal de Juiz de Fora/Campus Governador Valadares, Governador Valadares, Brazil.; Almeida-E-Silva DC; LabPIB, Department of Computing and Mathematics FFCLRP-USP, University of Sao Paulo, Ribeirao Preto, Brazil.; Andraos-Rey R; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ristov M; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Ambrósio L; Departmento de Análises Clínicas Toxicológicas e Bromatológicas da Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Brazil.; de Almeida FC; Departmento de Análises Clínicas Toxicológicas e Bromatológicas da Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Brazil.; de Souza Nunes N; Departmento de Análises Clínicas Toxicológicas e Bromatológicas da Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Brazil.; Xisto Souto E; Hospital Estadual de Transplantes Euryclides de Jesus Zerbini of São Paulo, São Paulo, Brazil.; de Lourdes Perobelli L; Hospital Estadual de Transplantes Euryclides de Jesus Zerbini of São Paulo, São Paulo, Brazil.; Simões BP; Departamento de Clínica Medica, Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil.; Alexander Guthy D; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Radimerski T; Disease Area Oncology, Novartis Institutes for BioMedical Research, Basel, Switzerland.; Attié de Castro F; Departmento de Análises Clínicas Toxicológicas e Bromatológicas da Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Brazil.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Academic Journal
Development Growth & Differentiation. Jul 01, 2001 43 Suppl 1:S3-S3
Academic Journal
Stivala S; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.; Codilupi T; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.; Brkic S; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.; Baerenwaldt A; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.; Ghosh N; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.; Hao-Shen H; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.; Dirnhofer S; Department of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.; Dettmer MS; Department of Pathology and.; Simillion C; Department of BioMedical Research, University of Berne, Berne, Switzerland.; Kaufmann BA; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.; Chiu S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Keller M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Kleppe M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Hilpert M; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.; Buser AS; Division of Hematology, University Hospital Basel, Basel, Switzerland.; Passweg JR; Division of Hematology, University Hospital Basel, Basel, Switzerland.; Radimerski T; Novartis Institutes for Biomedical Research, Basel, Switzerland.; Skoda RC; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.; Levine RL; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Meyer SC; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.; Division of Hematology, University Hospital Basel, Basel, Switzerland.
Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Radimerski, T
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어